|
慢阻肺的中西医治疗进展
|
Abstract:
慢阻肺是临床常见疾病之一,是一种常见的以持续气流受限为特征的可以预防和治疗的疾病,气流受限呈进行性发展,与气道和肺脏对有毒颗粒或气体的慢性炎性反应增强有关,急性加重和合并症影响患者整体疾病的严重程度,可进一步发展为肺心病和呼吸衰竭的常见慢性疾病。慢阻肺最为常见的症状是呼吸困难,慢性咳嗽(有时伴有痰),睡眠困难和感到疲倦,易并发其他疾病,常见的如呼吸衰竭、肺心症、自发性气胸、肺部感染及抑郁和焦虑。慢阻肺主要的发病因素分为环境因素和宿主因素,包括吸烟,工作习惯,素体虚弱等。目前对慢阻肺的治疗方式包括西医疗法、中医治疗和中西医结合法。西医治疗包括药物治疗、辅助通气治疗、长期氧疗等。中医治疗分为中医内治法和外治法,中西医结合法是将中医、西医结合的方法。本文就将以中西医治疗慢阻肺的相关概况给予总结,为防治此病提供参考。
Chronic obstructive pulmonary disease (COPD) is one of the common clinical diseases, characterized by persistent airflow limitation that is preventable and treatable. The airflow limitation is progressive and associated with an enhanced chronic inflammatory response in the airways and lungs to noxious particles or gases. Acute exacerbations and comorbidities affect the overall severity of the disease, which can further develop into common chronic conditions such as pulmonary heart disease and respiratory failure. The most common symptoms of COPD are dyspnea, chronic cough (sometimes with sputum), difficulty sleeping, and feeling tired. It is prone to complications such as respiratory failure, pulmonary heart disease, spontaneous pneumothorax, lung infections, depression, and anxiety. The main pathogenic factors of COPD are divided into environmental and host factors, including smoking, work habits, and constitutional weakness. Currently, the treatment options for COPD include Western medicine therapy, traditional Chinese medicine (TCM) therapy, and integrated traditional Chinese and Western medicine therapy. Western medicine treatment includes medication, assisted ventilation, long-term oxygen therapy, etc. TCM treatment is divided into internal and external therapies, while integrated traditional Chinese and Western medicine therapy combines both approaches. This article summarizes the relevant overview of the treatment of COPD with integrated traditional Chinese and Western medicine, providing a reference for the prevention and treatment of this disease.
[1] | Agustí, A., Celli, B.R., Criner, G.J., Halpin, D., Anzueto, A., Barnes, P., et al. (2023) Global Initiative for Chronic Obstructive Lung Disease 2023 Report: Gold Executive Summary. Respirology, 28, 316-338. https://doi.org/10.1111/resp.14486 |
[2] | Halpin, D.M.G., Criner, G.J., Papi, A., Singh, D., Anzueto, A., Martinez, F.J., et al. (2021) Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine, 203, 24-36. https://doi.org/10.1164/rccm.202009-3533so |
[3] | Quan, Z., Yan, G., Wang, Z., Li, Y., Zhang, J., Yang, T., et al. (2021) Current Status and Preventive Strategies of Chronic Obstructive Pulmonary Disease in China: A Literature Review. Journal of Thoracic Disease, 13, 3865-3877. https://doi.org/10.21037/jtd-20-2051 |
[4] | 翁佳丽, 李忱菲, 李锋. 臭氧对哮喘和慢性阻塞性肺病的影响及其机制研究进展[J]. 环境与职业医学, 2023, 40(8): 965-971. |
[5] | 李清, 郝福春. 坝上地区慢性阻塞性肺疾病高发原因分析[J]. 中外健康文摘, 2014(15): 12-13. |
[6] | 陈坤. 穴位贴敷联合呼吸康复训练治疗卒中后呼吸功能障碍的临床观察[D]: [硕士学位论文]. 北京: 北京中医药大学, 2023. |
[7] | Lakhdar, R., Denden, S., Kassab, A., Leban, N., Knani, J., Lefranc, G., et al. (2011) Update in Chronic Obstructive Pulmonary Disease: Role of Antioxidant and Metabolizing Gene Polymorphisms. Experimental Lung Research, 37, 364-375. https://doi.org/10.3109/01902148.2011.580416 |
[8] | Yildirim, E., Kormi, I., Başoğlu, Ö.K., Gürgün, A., Kaval, B., Sorsa, T., et al. (2012) Periodontal Health and Serum, Saliva Matrix Metalloproteinases in Patients with Mild Chronic Obstructive Pulmonary Disease. Journal of Periodontal Research, 48, 269-275. https://doi.org/10.1111/jre.12004 |
[9] | 姜丹. 抗胆碱药联合支气管舒张剂在慢阻肺患者治疗中的应用研究[J]. 中国现代药物应用, 2021, 15(23): 160-162. |
[10] | 杨秀菊, 陈俊. 糖皮质激素对慢阻肺合并肺部感染患者肺功能及炎症因子水平的影响[J]. 中国实用医药, 2023, 18(22): 17-20. |
[11] | 张志萍, 胡显凤, 毛昌立. 无创辅助通气对慢性阻塞性肺疾病患者膈肌功能的影响[J]. 广东医学, 2023, 44(6): 760-765. |
[12] | 伍尚光. 长期氧疗联合肺康复功能锻炼对慢阻肺并合肺心病的疗效评价[J]. 中国现代药物应用, 2020, 14(19): 226-228. |
[13] | 王奕萱. 定喘汤加味联合中药穴位贴敷治疗慢阻肺急性加重期50例[J]. 中国中医药科技, 2023, 30(5): 977-979. |
[14] | 张持萍, 倪苏侠, 王君君. 加味三子养亲汤治疗急性发作期慢阻肺患者的临床疗效探讨[J]. 中外医疗, 2023, 42(17): 180-183, 187. |
[15] | 丛红梅. 头针联合中药治疗慢性阻塞性肺疾病稳定期伴轻度抑郁症状的临床疗效评价[D]: [硕士学位论文]. 济南: 山东中医药大学, 2023. |
[16] | 孙婷煜, 刘玉丽, 段晓莹. 中医药干预哮喘的机制研究进展[J]. 湖南中医杂志, 2022, 38(3): 180-184. |
[17] | 张强. 针灸结合三子养亲汤加味辅治慢性阻塞性肺疾病急性加重期临床观察[J]. 实用中医药杂志, 2022, 38(8): 1392-1394. |
[18] | 石琛, 高瑜, 刘红艳, 姬文兰, 胡萍. 百令胶囊联合复方异丙托溴铵治疗慢性阻塞性肺疾病急性加重期患者的临床研究[J]. 中国临床药理学杂志, 2024, 40(3): 317-320. |
[19] | 刘敬敬, 程玉峰, 崔磊. 化痰止咳平喘汤联合布地奈德治疗慢性阻塞性肺疾病急性加重期临床研究[J]. 陕西中医, 2024, 45(2): 204-207. |